Evidence method
Level · gp.fundamentals.capex_revenue_ratio
4.44% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
ANIK · Jun 30, 2026
Anika Therapeutics, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001171843-26-005012General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-2.10% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
15.56% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
87.60% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
65.15% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
9.06% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
22.51% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
5.62% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History15 statesHistory building
Dec 31, 20220/7 normalizedLevel 3Mar 31, 20230/7 normalizedLevel 3Jun 30, 20230/7 normalizedLevel 3Sep 30, 20230/7 normalizedLevel 3Dec 31, 20230/8 normalizedLevel 3Mar 31, 20240/8 normalizedLevel 3Jun 30, 20240/8 normalizedLevel 3Sep 30, 20240/8 normalizedLevel 3Dec 31, 20247/8 normalizedLevel 3Mar 31, 20257/8 normalizedLevel 3Jun 30, 20257/8 normalizedLevel 3Sep 30, 20256/7 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 4.83%
- Current
- 4.44%
- Delta
- -0.39%
- Previous
- -16.36%
- Current
- -2.10%
- Delta
- 14.27%
- Previous
- 13.16%
- Current
- 15.56%
- Delta
- 2.40%
- Previous
- 77.12%
- Current
- 87.60%
- Delta
- 10.47%
- Previous
- 64.15%
- Current
- 65.15%
- Delta
- 0.99%
- Previous
- -18.53%
- Current
- 9.06%
- Delta
- 27.59%
- Previous
- 22.67%
- Current
- 22.51%
- Delta
- -0.16%
- Previous
- 22.43%
- Current
- 5.62%
- Delta
- -16.81%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Compared To · Surgical & Medical Instruments & Apparatus peers →Derived From · ANIK Company Quality Vector →Has State · Anika Therapeutics, Inc. →Transitioned To · ANIK Fundamental State →Transitioned To · ANIK CAPEX_INTENSITY_DECREASED →Transitioned To · ANIK CASH_GENERATION_INCREASED →Transitioned To · ANIK GROWTH_INCREASED →Transitioned To · ANIK INVENTORY_PRESSURE_INCREASED →Transitioned To · ANIK MARGIN_INCREASED →Transitioned To · ANIK PROFITABILITY_INCREASED →Transitioned To · ANIK R_AND_D_INTENSITY_DECREASED →Transitioned To · ANIK SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.